Multiple Sclerosis: Imaging

Magnetic resonance imaging (MRI) has been used to diagnose and monitor disease progression in multiple sclerosis (MS). MRI has improved the management of MS patients and provided information on the level of atrophy in the brain and the severity of the disease. Discover the latest research on multiple sclerosis imaging here.

April 18, 2021

Assessment of the genetic contribution to brain MRI lesion load and atrophy measures in multiple sclerosis patients.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Ferdinando ClarelliMassimo Filippi
April 18, 2021

Characterization of chronic active multiple sclerosis lesions with sodium (23 Na) MRI - preliminary observations.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Philipp EiseleAchim Gass
April 18, 2021
Open Access

Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorders by multiparametric quantitative MRI using convolutional neural network.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Akifumi HagiwaraShigeki Aoki
April 16, 2021

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation.

Multiple Sclerosis : Clinical and Laboratory Research
Graham CooperFriedemann Paul
April 16, 2021

Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.

Multiple Sclerosis : Clinical and Laboratory Research
Elisabetta SignorielloAlessio Signori
April 15, 2021

Cortico-subcortical functional connectivity modifications in fatigued ms patients treated with fampridine and amantadine.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Maria RoccaMassimo Filippi
April 14, 2021
Review
Open Access

The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Adam J Schwarz
April 12, 2021
Open Access

Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Aurora ZanghìEmanuele D'Amico
April 11, 2021
Open Access

Longitudinal imaging of T-cells and inflammatory demyelination in a preclinical model of multiple sclerosis using 18F-FAraG PET and MRI.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Caroline GuglielmettiMyriam M Chaumeil
April 11, 2021

Serum inflammatory markers in patients with multiple sclerosis and their association with clinical manifestations and MRI findings.

Acta neurologica Belgica
Masoume NazeriAmin Abolhasani Foroughi
April 11, 2021

Clinical and radiological activity of secondary progressive multiple sclerosis in a population-based cohort.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Guillaume MatheyJonathan Epstein
April 8, 2021
Open Access

Delayed access to conscious processing in multiple sclerosis: Reduced cortical activation and impaired structural connectivity.

Human Brain Mapping
Arzu C Has SilemekJan-Patrick Stellmann
April 10, 2021

A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Anna Isabella PisaniMassimiliano Calabrese
April 9, 2021

The role of optical coherence tomography in the diagnosis of afferent visual pathway problems: A neuroophthalmic perspective.

Handbook of Clinical Neurology
Fiona Costello, John J Chen
April 8, 2021

Long-Term Effectiveness of Fingolimod for Multiple Sclerosis in a Real-World Clinical Setting.

European Neurology
Cihat UzunköprüSabiha Türe
April 8, 2021
Open Access

Relevance of Brain MRI in Patients with Uveitis: Retrospective Cohort on 402 Patients.

Ocular Immunology and Inflammation
N ChirpazP Sève

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-imaging/690d08df-dded-4a18-9a21-bcac5805b09d